Iodixanol Injection Shortage
Last Updated: June 20, 2023
Status: Current
Reason for the Shortage
-
- GE Healthcare has Visipaque presentations available.
- Fresenius Kabi launched iodixanol in mid-July 2022. The company is marketing and distributing iodixanol for Jiangsu Hergrui Pharmaceuticals in the US.
Available Products
-
- Visipaque solution for injection, GE Healthcare, 270 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-17
- Visipaque solution for injection, GE Healthcare, 270 mg/mL, 150 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-19
- Visipaque solution for injection, GE Healthcare, 270 mg/mL, 200 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-21
- Visipaque solution for injection, GE Healthcare, 270 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-2222-16
- Visipaque solution for injection, GE Healthcare, 320 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-17
- Visipaque solution for injection, GE Healthcare, 320 mg/mL, 150 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-19
- Visipaque solution for injection, GE Healthcare, 320 mg/mL, 200 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-21
- Visipaque solution for injection, GE Healthcare, 320 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-16
- Visipaque solution for injection, GE Healthcare, 320 mg/mL, 500 mL +PLUSPAK bottle, 10 count, NDC 00407-2223-23
- Iodixanol solution for injection, Fresenius Kabi, 270 mg/mL, 100 mL bottle, 10 count, NDC 65219-0381-10
- Iodixanol solution for injection, Fresenius Kabi, 270 mg/mL, 150 mL bottle, 10 count, NDC 65219-0381-50
- Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 100 mL bottle, 10 count, NDC 65219-0383-10
- Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 150 mL bottle, 10 count, NDC 65219-0383-50
- Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 200 mL bottle, 10 count, NDC 65219-0383-70
- Iodixanol solution for injection, Fresenius Kabi, 320 mg/mL, 50 mL bottle, 10 count, NDC 65219-0383-05
Estimated Resupply Dates
-
- All marketed presentations are available.
Alternative Agents & Management
-
- Non-ionic, low osmolality contrast media in current use include iopamidol, iohexol, iopromide, and ioversol.
- Iodixanol (iso-osmolality agent) is also included in the low osmolality contrast media category.[1]
References
-
- ACR Manual on Contrast Media. American College of Radiology. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf. 2021.
Updated
Updated June 20, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 12, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.